Compounds, compositions and methods for modulating the activity of nuclear
receptors are provided. In particular, heterocyclic compounds are
provided for modulating the activity of farnesoid X receptor (FXR), liver
X receptor (LXR) and/or orphan nuclear receptors. In certain embodiments,
the compounds are thiazolidinone derivatives.